Laparoscopic versus open hepatectomy for hepatocellular carcinoma following conversion therapy: A systematic review and meta-analysis.

医学 肝细胞癌 荟萃分析 肝切除术 癌 外科 普通外科 肿瘤科 内科学 切除术
作者
Gabriele Eckerdt Lech,Patricia Viana,Raquel Oliveira de Sousa Silva,Bárbara Vieira Lima Aguiar Melão,Camila Mariana de Paiva Reis,Edgar Paulo da Silva Neto,João Luís Reis Freitas,Rafael Morriello
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:42 (16_suppl): e16272-e16272
标识
DOI:10.1200/jco.2024.42.16_suppl.e16272
摘要

e16272 Background: Conversion therapy for hepatocellular carcinoma (HCC) has emerged as a novel strategy allowing patients with previously unresectable HCC to transition to a resectable disease through a combination of therapies. Laparoscopic hepatectomy is associated with reduced blood loss and early recovery without compromising oncological results in cirrhotic patients. However, the specific benefits of laparoscopic hepatectomy in patients who have undergone conversion therapy are not clear. Methods: We searched PubMed, Embase, and Cochrane Central for any studies that compared laparoscopic versus open hepatectomy after the use of conversion therapy (transarterial chemoembolization, portal vein embolization, hepatic arterial infusion chemotherapy, or liver ablation) in patients with hepatocellular carcinoma. The outcomes of interest were length of hospital stay, blood loss, operative time, pedicle clamping, postoperative complications, and transfusion. Statistical analysis was performed using R statistical software 4.2.1. Heterogeneity was assessed with I². Results: We included 535 patients from 4 retrospective nonrandomized studies. The mean age in the laparoscopic group was 60.33, ranging from 29 to 83. Length of hospital stay was significantly reduced in the laparoscopic group (MD -5.01; 95% CI -9.76–-0.27; p = 0.04; I² = 92%), as well as the blood loss (MD -97.26; 95% CI -200.54–6.01; p = 0.06; I² = 76%). Postoperative complications also favored the laparoscopic group (OR 0.40; 95% CI 0.17–0.94; p = 0.035; I² = 0%). The endpoints of pedicle clamping (OR 0.7; 95% CI 0.11–4.36; p = 0.70; I² = 91%), transfusion (OR 0.69; 95% CI 0.36–1.33; p = 0.273; I² = 0%), and operative time (MD 34.21; 95% CI -36.68–105.10; p = 0.34; I² = 97%) did not favor any of the groups. Conclusions: In this meta-analysis, laparoscopic hepatectomy after conversion therapy was proven to be safe and feasible, without significant differences compared to open hepatectomy regarding pedicle clamping, transfusion, and operative time. Furthermore, the laparoscopic group presented less blood loss and a significantly reduced length of hospital stay. These findings suggest that laparoscopic resection could be safely used after conversion therapy and may improve surgical outcomes in these patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Serendipity发布了新的文献求助10
刚刚
汤圆发布了新的文献求助10
1秒前
海鲸发布了新的文献求助20
1秒前
在望的应助被肖馨余采纳,获得10
1秒前
爱撒娇的朋友完成签到,获得积分10
2秒前
烟花的应助被flash采纳,获得10
3秒前
积极亦竹发布了新的文献求助10
3秒前
xiaxi完成签到,获得积分10
5秒前
ding的应助被xielaoban采纳,获得10
5秒前
6秒前
荼蘼发布了新的文献求助10
6秒前
7秒前
朴实颤完成签到,获得积分10
7秒前
8秒前
8秒前
chuqing发布了新的文献求助10
8秒前
momo完成签到,获得积分10
8秒前
无私的迎松完成签到,获得积分10
10秒前
YYJ完成签到,获得积分10
10秒前
酷波er的应助被积极亦竹采纳,获得10
11秒前
BAEKHYUNLUCKY发布了新的文献求助10
13秒前
13秒前
13秒前
13秒前
尘_发布了新的文献求助10
14秒前
BernardGo发布了新的文献求助10
17秒前
荼蘼发布了新的文献求助10
17秒前
慈祥的丹寒完成签到 ,获得积分10
21秒前
21秒前
冯老三完成签到 ,获得积分10
22秒前
Maestro_S的应助被chuqing采纳,获得10
22秒前
howeVer完成签到 ,获得积分10
22秒前
槟洛完成签到,获得积分10
22秒前
月亮代表我的心完成签到,获得积分10
23秒前
黄大树完成签到,获得积分10
23秒前
高挑的伊完成签到,获得积分10
24秒前
正直的又柔完成签到,获得积分10
25秒前
丘比特的应助被老年学术废物采纳,获得10
25秒前
Long发布了新的文献求助10
25秒前
xixilulixiu完成签到 ,获得积分0
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175157
求助须知:如何正确求助?哪些是违规求助? 9566955
关于积分的说明 21789278
捐赠科研通 7769593
什么是DOI,文献DOI怎么找? 3431836
关于科研通互助平台的介绍 2556078
邀请新用户注册赠送积分活动 2477241